Report Thumbnail
Product Code LP091190946I21
Published Date 2023/1/12
English117 PagesGlobal

Global Valine Market Growth 2023-2029Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP091190946I21◆The Jan 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/1/12
English 117 PagesGlobal

Global Valine Market Growth 2023-2029Pharmaceutical_LifeSciense Market



Abstract


Summary

Valine is an amino acid necessary for human health. It is known as a branched chain amino acid (BCAA). Valine is responsible for encouraging normal human growth, repairing tissue, and regulating blood sugar. This report mainly covers the Valine product type L-Valine and D-Valine, Feed, food, and Medicine by application, while we can also offer any product survey report related to the Valine industry chain. LPI (LP Information)' newest research report, the “Valine Industry Forecast” looks at past sales and reviews total world Valine sales in 2022, providing a comprehensive analysis by region and market sector of projected Valine sales for 2023 through 2029. With Valine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valine industry. This Insight Report provides a comprehensive analysis of the global Valine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Valine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valine. The global Valine market size is projected to grow from US$ 287.6 million in 2022 to US$ 346.5 million in 2029; it is expected to grow at a CAGR of 346.5 from 2023 to 2029. At present, the Valine production market concentrates in USA, Europe, China, Japan. China is the largest production country of valine in the world in the past few years and it will keep the same position in the next few years. The China market took up about28.67% the global market. This report presents a comprehensive overview, market shares, and growth opportunities of Valine market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type L-Valine D-Valine Others Segmentation by application Feed Food Medicine Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Ajinomoto Kyowa Hakko Evonik CJ Fufeng Group Maidan Biology Meihua Group Sanxia Pharmaceutical Tianjin Tianan Wellman Bioscience Jinghai Amino Acid Bafeng Pharmaceutical Jiahe Biotech Luzhou Group Jirong Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Valine market? What factors are driving Valine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Valine market opportunities vary by end market size? How does Valine break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Valine Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Valine by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Valine by Country/Region, 2018, 2022 & 2029
    • 2.2 Valine Segment by Type
      • 2.2.1 L-Valine
      • 2.2.2 D-Valine
      • 2.2.3 Others
    • 2.3 Valine Sales by Type
      • 2.3.1 Global Valine Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Valine Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Valine Sale Price by Type (2018-2023)
    • 2.4 Valine Segment by Application
      • 2.4.1 Feed
      • 2.4.2 Food
      • 2.4.3 Medicine
      • 2.4.4 Other
    • 2.5 Valine Sales by Application
      • 2.5.1 Global Valine Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Valine Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Valine Sale Price by Application (2018-2023)
  • 3 Global Valine by Company

    • 3.1 Global Valine Breakdown Data by Company
      • 3.1.1 Global Valine Annual Sales by Company (2018-2023)
      • 3.1.2 Global Valine Sales Market Share by Company (2018-2023)
    • 3.2 Global Valine Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Valine Revenue by Company (2018-2023)
      • 3.2.2 Global Valine Revenue Market Share by Company (2018-2023)
    • 3.3 Global Valine Sale Price by Company
    • 3.4 Key Manufacturers Valine Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Valine Product Location Distribution
      • 3.4.2 Players Valine Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Valine by Geographic Region

    • 4.1 World Historic Valine Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Valine Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Valine Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Valine Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Valine Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Valine Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Valine Sales Growth
    • 4.4 APAC Valine Sales Growth
    • 4.5 Europe Valine Sales Growth
    • 4.6 Middle East & Africa Valine Sales Growth
  • 5 Americas

    • 5.1 Americas Valine Sales by Country
      • 5.1.1 Americas Valine Sales by Country (2018-2023)
      • 5.1.2 Americas Valine Revenue by Country (2018-2023)
    • 5.2 Americas Valine Sales by Type
    • 5.3 Americas Valine Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Valine Sales by Region
      • 6.1.1 APAC Valine Sales by Region (2018-2023)
      • 6.1.2 APAC Valine Revenue by Region (2018-2023)
    • 6.2 APAC Valine Sales by Type
    • 6.3 APAC Valine Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Valine by Country
      • 7.1.1 Europe Valine Sales by Country (2018-2023)
      • 7.1.2 Europe Valine Revenue by Country (2018-2023)
    • 7.2 Europe Valine Sales by Type
    • 7.3 Europe Valine Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Valine by Country
      • 8.1.1 Middle East & Africa Valine Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Valine Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Valine Sales by Type
    • 8.3 Middle East & Africa Valine Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Valine
    • 10.3 Manufacturing Process Analysis of Valine
    • 10.4 Industry Chain Structure of Valine
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Valine Distributors
    • 11.3 Valine Customer
  • 12 World Forecast Review for Valine by Geographic Region

    • 12.1 Global Valine Market Size Forecast by Region
      • 12.1.1 Global Valine Forecast by Region (2024-2029)
      • 12.1.2 Global Valine Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Valine Forecast by Type
    • 12.7 Global Valine Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Ajinomoto
      • 13.1.1 Ajinomoto Company Information
      • 13.1.2 Ajinomoto Valine Product Portfolios and Specifications
      • 13.1.3 Ajinomoto Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Ajinomoto Main Business Overview
      • 13.1.5 Ajinomoto Latest Developments
    • 13.2 Kyowa Hakko
      • 13.2.1 Kyowa Hakko Company Information
      • 13.2.2 Kyowa Hakko Valine Product Portfolios and Specifications
      • 13.2.3 Kyowa Hakko Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Kyowa Hakko Main Business Overview
      • 13.2.5 Kyowa Hakko Latest Developments
    • 13.3 Evonik
      • 13.3.1 Evonik Company Information
      • 13.3.2 Evonik Valine Product Portfolios and Specifications
      • 13.3.3 Evonik Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Evonik Main Business Overview
      • 13.3.5 Evonik Latest Developments
    • 13.4 CJ
      • 13.4.1 CJ Company Information
      • 13.4.2 CJ Valine Product Portfolios and Specifications
      • 13.4.3 CJ Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 CJ Main Business Overview
      • 13.4.5 CJ Latest Developments
    • 13.5 Fufeng Group
      • 13.5.1 Fufeng Group Company Information
      • 13.5.2 Fufeng Group Valine Product Portfolios and Specifications
      • 13.5.3 Fufeng Group Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Fufeng Group Main Business Overview
      • 13.5.5 Fufeng Group Latest Developments
    • 13.6 Maidan Biology
      • 13.6.1 Maidan Biology Company Information
      • 13.6.2 Maidan Biology Valine Product Portfolios and Specifications
      • 13.6.3 Maidan Biology Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 Maidan Biology Main Business Overview
      • 13.6.5 Maidan Biology Latest Developments
    • 13.7 Meihua Group
      • 13.7.1 Meihua Group Company Information
      • 13.7.2 Meihua Group Valine Product Portfolios and Specifications
      • 13.7.3 Meihua Group Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 Meihua Group Main Business Overview
      • 13.7.5 Meihua Group Latest Developments
    • 13.8 Sanxia Pharmaceutical
      • 13.8.1 Sanxia Pharmaceutical Company Information
      • 13.8.2 Sanxia Pharmaceutical Valine Product Portfolios and Specifications
      • 13.8.3 Sanxia Pharmaceutical Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 Sanxia Pharmaceutical Main Business Overview
      • 13.8.5 Sanxia Pharmaceutical Latest Developments
    • 13.9 Tianjin Tianan
      • 13.9.1 Tianjin Tianan Company Information
      • 13.9.2 Tianjin Tianan Valine Product Portfolios and Specifications
      • 13.9.3 Tianjin Tianan Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 Tianjin Tianan Main Business Overview
      • 13.9.5 Tianjin Tianan Latest Developments
    • 13.10 Wellman Bioscience
      • 13.10.1 Wellman Bioscience Company Information
      • 13.10.2 Wellman Bioscience Valine Product Portfolios and Specifications
      • 13.10.3 Wellman Bioscience Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.10.4 Wellman Bioscience Main Business Overview
      • 13.10.5 Wellman Bioscience Latest Developments
    • 13.11 Jinghai Amino Acid
      • 13.11.1 Jinghai Amino Acid Company Information
      • 13.11.2 Jinghai Amino Acid Valine Product Portfolios and Specifications
      • 13.11.3 Jinghai Amino Acid Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.11.4 Jinghai Amino Acid Main Business Overview
      • 13.11.5 Jinghai Amino Acid Latest Developments
    • 13.12 Bafeng Pharmaceutical
      • 13.12.1 Bafeng Pharmaceutical Company Information
      • 13.12.2 Bafeng Pharmaceutical Valine Product Portfolios and Specifications
      • 13.12.3 Bafeng Pharmaceutical Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.12.4 Bafeng Pharmaceutical Main Business Overview
      • 13.12.5 Bafeng Pharmaceutical Latest Developments
    • 13.13 Jiahe Biotech
      • 13.13.1 Jiahe Biotech Company Information
      • 13.13.2 Jiahe Biotech Valine Product Portfolios and Specifications
      • 13.13.3 Jiahe Biotech Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.13.4 Jiahe Biotech Main Business Overview
      • 13.13.5 Jiahe Biotech Latest Developments
    • 13.14 Luzhou Group
      • 13.14.1 Luzhou Group Company Information
      • 13.14.2 Luzhou Group Valine Product Portfolios and Specifications
      • 13.14.3 Luzhou Group Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.14.4 Luzhou Group Main Business Overview
      • 13.14.5 Luzhou Group Latest Developments
    • 13.15 Jirong Pharmaceutical
      • 13.15.1 Jirong Pharmaceutical Company Information
      • 13.15.2 Jirong Pharmaceutical Valine Product Portfolios and Specifications
      • 13.15.3 Jirong Pharmaceutical Valine Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.15.4 Jirong Pharmaceutical Main Business Overview
      • 13.15.5 Jirong Pharmaceutical Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.